Eli Lilly CEO David Ricks on $1T market value, obesity pill launch and drug pipeline outlookJanuary 13, 2026
Share Facebook Twitter LinkedIn Pinterest Email Rob Rowe, Citi Research head of global strategy, joins CNBC’s ‘Money Movers’ to discuss the Fed’s rate cut path, why he sees more easing ahead, and what it means for stocks, gold, and the labor market.